Revue Neurologique

Article	Citations
Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations	180
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians	137
COVID-19 may induce Guillain–Barré syndrome	131
Covid-19 and Guillain-Barré syndrome: More than a coincidence!	90
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network	63
First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case	63
Parkinson's disease: From bench to bedside	45
Epidemiology of neurological diseases in older adults	45
The effects of diet and sex in amyotrophic lateral sclerosis	42
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects	40
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention	39
CGRP and migraine: from bench to bedside	36
Acute meningoencephalitis in a patient with COVID-19	33
Vitamin D serum levels in patients with migraine: A meta-analysis	33
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection	30
Neurofeedback for cognitive enhancement and intervention and brain plasticity	25
Etiological assessment of status epilepticus	25
Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)	24
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment	24
Pregnancy with multiple sclerosis	23
Clinical and genetic update of hereditary spastic paraparesis	22
Syringomyelia and hydromyelia: Current understanding and neurosurgical management	22
Therapeutic news in ALS	21
Migraine with aura	20
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis	18

French guidelines for neuropathic pain: An update and commentary	18
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment	17
From competition to cooperation: Visual neglect across the hemispheres	16
Functional movement disorders	16
Spinal cord stimulation for neuropathic pain	16
FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS	16
Spinal cord injury pain	16
Nonconvulsive status epilepticus in the elderly	15
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19	15
Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants	15
Genetics of migraine	15
Brain plasticity and hearing disorders	15
Lafora disease: Current biology and therapeutic approaches	15
Stroke in women: When gender matters	15
Primary Lateral Sclerosis: Clinical, radiological and molecular features	15
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis	14
MRI characteristics of MOG-Ab associated disease in adults: An update	14
Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…	14
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?	14
Intracerebral hemorrhage in CADASIL	14
No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients	14
Deep brain stimulation programming in Parkinson's disease: Introduction of current issues and perspectives	14
Genetic/idiopathic generalized epilepsies: Not so good as that!	14
Association of obesity with recurrent stroke and cardiovascular events	14
Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society	13
The death of localizationism: The concepts of functional connectome and neuroplasticity deciphered by awake mapping, and their implications for best care of brain-damaged patients	13
Self-perceived attention difficulties are associated with sensory hypersensitivity in migraine	13
Carotid webs associated with ischemic stroke. Updated general review and research directions	13
What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics	13
Repair strategies for traumatic spinal cord injury, with special emphasis on novel biomaterial-based approaches	12
Imaging of the spine and spinal cord: An overview of magnetic resonance imaging (MRI) techniques	12
Migraine in multiple sclerosis and other chronic inflammatory diseases	12
What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature	12
Relationships between migraine and epilepsy: Pathophysiological mechanisms and clinical implications	12
Chronic pain in Parkinson's disease: Clinical and pathophysiological aspects	12
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in	12
Medical treatment of Rasmussen's Encephalitis: A systematic review	12
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment	12
Will MRI replace the EEG for the diagnosis of nonconvulsive status epilepticus, especially focal?	11
Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges	11
Spinal cord injury: A multisystem physiological impairment/dysfunction	11
Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre	11
Normal ageing of the brain: Histological and biological aspects	11
Correlation between blood glucose variability and the risk of death in patients with severe acute stroke	11
Artificial intelligence and ChatGPT between worst enemy and best friend: The two faces of a revolution and its impact on science and medical schools	11
Intensive care unit-acquired weakness: Questions the clinician should ask	11
Cortical excitability in migraine: Contributions of magnetic resonance imaging	11
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study	11
Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration	11
Area postrema syndrome as initial manifestation in neuromyelitis optica spectrum disorder patients: A retrospective study	10

Functional Neurological Disorders in the medical education: An urgent need to fill the gaps	10
Prevalence of stroke survivors in Parakou in northern Benin: A door-to-door community survey	10
Predictors of malignant middle cerebral artery infarction after mechanical thrombectomy	10
A historical approach to hereditary spastic paraplegia	10
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review	10
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum	10
Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report	10
Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly	9
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study	9
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients	9
The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage	9
Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults	9
Neuropathy of the elderly	9
Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies	9
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society	9
Covid-19, the pandemic war: Implication for neurologists	9
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2	9
Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine	9
Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?	8
Serum cortisol levels in patients with a transient global amnesia	8
Influence of inflammatory status in the acute phase of stroke on post-stroke depression	8
Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis	8
Immunomodulation in the acute phase of autoimmune encephalitis	8
Phenotypic variability in amyotrophic lateral sclerosis	8
Limb shaking transient ischemic attacks: A follow-up of 28 patients	8
Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS)	8
Acute telestroke in France: A systematic review	8
Social cognition in epilepsy: State of the art and perspectives	8
Headache associated with refractive errors: Characteristics and risk factors	8
Visual and motor neglect: Clinical and neurocognitive aspects	7
Toward a coherent structuration of disorders of consciousness expertise at a country scale: A proposal for France	7
Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, assumptions and new perspectives	7
Prognostic value of spinal cord MRI in multiple sclerosis patients	7
Alexithymia in multiple sclerosis: Clinical and radiological correlations	7
Severe migraine and its control: A proposal for definitions and consequences for care	7
Management of intramedullary spinal cord tumors: A single-center experience of 247 patients	7
Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population	7
Therapeutic ultrasound: The future of epilepsy surgery?	7
Metabolic alterations in spinal and bulbar muscular atrophy	7
Cognitive deficit, and neuropathological correlates, in the oldest-old	7
Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies	7
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes	7
Social and emotional cognition in patients with severe migraine consulting in a tertiary headache center: A preliminary study	7
EEG: Current relevance and promising quantitative analyses	7
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series	7
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's disease	6
Genetics and familial distribution of multiple sclerosis: A review	6
Contribution of muscle MRI for diagnosis of myopathy	6
Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: A randomized parallel-controlled single-blind clinical trial	6
What contribution can genetics make to predict the risk of Alzheimer's disease?	6
Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study	6
Clinical and biochemical markers in CIPN: A reappraisal	6
Endovascular therapy for acute ischemic stroke: The importance of blood pressure control, sedation modality and anti-thrombotic management to improve functional outcomes	6
Neuro-ChatGPT? Potential threats and certain opportunities	6
Negative motor networks: Electric cortical stimulation and diffusion tensor imaging	6
Comparisons of electrophysiological and clinical findings between young and elderly patients with Carpal Tunnel Syndrome	6
Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach	6
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology	6
Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study	6
Motor reserve: How to build neuronal resilience against ageing and neurodegeneration?	6
Degenerative cervical myelopathy	6
Lennox-Gastaut syndrome: New treatments and treatments under investigation	6
Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition	6
Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR)	6
Challenges in diagnosis and management of adult spinal cord gliomas	6
Headaches during pregnancy	5
FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis	5
Another extensive nitrous oxide (N2O) myelopathy: The wood for the trees?	5
Narcolepsies, update in 2023	5
Epilepsy and pregnancy: What should the neurologists do?	5
The role of neuropsychological assessment in adults with attention deficit/hyperactivity disorders	5
Cerebrovascular events during pregnancy and puerperium	5
Health issues in polyhandicapped patients according to age: Results of a large French cross-sectional study	5
Armand Trousseau (1801–1867), a neurologist before neurology	5
Epilepsy – from mysticism to science	5
Strategy for genetic analysis in hereditary neuropathy	5
Low back pain in patients with multiple sclerosis: A systematic review and the prevalence in a French multiple sclerosis population	5
Getting older with chronic temporal lobe epilepsy: What memory profile?	5
Neurological adverse events of immune checkpoint inhibitors: An update of clinical presentations, diagnosis, and management	5
Intracranial nociception	5

Overcoming the blood brain barrier in glioblastoma: Status and future perspective	5
Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients	5
How to treat neurogenic bladder and sexual dysfunction after spinal cord lesion	5
Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies	5
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective study	5
Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature	5
Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data	5
The COVID-19 pandemic, an environmental neurology perspective	5
Medication overuse headache: Updating of the French recommendations regarding the treatment strategies	5
Sleep and armed conflict: future complications of war in Ukraine	5
Interest of registries in neuropathic pain research	5
Recent advances in the diagnosis and the treatment of primary CNS lymphoma	5
Wearable devices for seizure detection: Is it time to translate into our clinical practice?	5
Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson's disease	5
Imaging of the aging brain and development of MRI signal abnormalities	5
Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis	5
The various forms of sensorimotor plasticity following limb amputation and their link with rehabilitation strategies	4
Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease	4
Neuropathy and pregnancy: An overview	4
The Marquise de Dampierre identified at last, the first described clinical case of Gilles de la Tourette syndrome	4
Long-term cognitive outcomes in patient with epilepsy	4
New onset refractory status epilepticus: State of the art	4
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France	4
Are there socio-economic inequities in access to reperfusion therapy: The stroke 69 cohort	4
Transcranial Doppler findings in a population with clinical probable reversible cerebral vasoconstriction syndrome	4
The current international consensus criteria can lead to under and over-diagnosis of primary progressive aphasia variants	4
Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach	4
Development and initial validation of the polyhandicap severity scale	4
Intensive care management of patients with viral encephalitis	4
Post infectious encephalitis at Covid19: About one pediatric observation and review of the literature	4
Management of glioblastomas in the elderly population	4
Iatrogenesis and neurological manifestations in the elderly	4
Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?	4
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease	4
Things you wanted to know (but might have been afraid to ask) about how and why to explore and modulate brain plasticity with non-invasive neurostimulation technologies	4
Anatomical and neurophysiological basis of face recognition	4
Mini review – The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease	4
Seizure incidence among neuromyelitis optica spectrum disorder patients	4
General anesthesia or conscious sedation for endovascular therapy of basilar artery occlusions: ETIS registry results	4
An inventory of basic research in temporal lobe epilepsy	4
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?	4
Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis	4
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients	4
Neuro-Leptospirosis: Experience from a tertiary center of North India	4
Neuromuscular manifestations of lead poisoning in opium and herbal users in Iran	4
An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)	4
From the wax cast of brain ventricles (1508-9) by Leonardo da Vinci to air cast ventriculography (1918) by Walter E. Dandy	4
Oral and intestinal dysbiosis in Parkinson's disease	4
Diagnostic and therapeutic approach to adult central nervous system vasculitis	4
Pregnancy and myopathies: Reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review	4
Parkinsonian gait in elderly people: Significance of the threshold value of two and more falls per year	3
Does post dural puncture headache exist in idiopathic intracranial hypertension? A pilot study	3
Acute and Post-Traumatic Stress Disorders: A biased nervous system	3
Early hyperdopaminergic state following sub-thalamic nucleus deep brain stimulation in Parkinson disease	3
Intracerebral haemorrhage, microbleeds and antithrombotic drugs	3
Endogenous melatonin levels and therapeutic use of exogenous melatonin in tension type headache: A systematic review	3
Spinal cord tractopathy in paraneoplastic anti-CV2/CRMP5 myelitis responsive to plasma exchange	3
Weaning from mechanical ventilation in neurocritical care	3
Therapeutic tools for familial ALS	3
Diagnostic and therapeutic issues of inflammatory diseases of the elderly	3
Reversible parkinsonism and FTD due to spontaneous intracranial hypotension	3
COVID-19: A putative trigger for neuralgic amyotrophy	3
Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach	3
Spinal cord arterio-venous shunts: From classification to therapeutic management	3
Daylight saving time and the incidence of thrombolysis to treat acute ischemic stroke	3
Efficacy of microvascular decompression on the vascular compression type of neurogenic hypertension: A meta-analysis	3
All that glitters is not gold: A limbic encephalitis due to neurosyphilis	3
Clinical, electrophysiological and genetic characteristics of childhood hereditary polyneuropathies	3
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)	3
Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview	3
CSF biomarkers in primary CNS lymphoma	3
Changes in neuromuscular function in elders: Novel techniques for assessment of motor unit loss and motor unit remodeling with aging	3
Acute stroke care in France: Survey in the 138 stroke units	3
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination	3
Factors affecting the outcome of delayed intravenous thrombolysis (> 4.5 hours)	3
A descriptive monocentric study in Algeria of adults with cerebral venous thrombosis	3
Myasthenia gravis and pregnancy	3
Awareness dimensions and associated factors in Alzheimer's disease	3
High glycemic variability: An underestimated determinant of stroke functional outcome following large vessel occlusion	3
Estimated number of eligible patients for mechanical thrombectomy based on NIHSS and population-based Brest stroke registry	3
How we sleep: From brain states to processes	3
Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report	3
Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease	3
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review	3
Retrospective evaluation of regional telemedicine team meetings for multiple sclerosis (MS) patients: Experience from the Caen MS expert center in Normandy, France	3
Contrast enhanced ultrasound of carotid plaque in acute ischemic stroke (CUSCAS study)	3
Fluoxetine-induced chorea	3
Depression could modulate neuropsychological status in epilepsy	3
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment	3
An educational case series of Parkinson's disease during the COVID-19 pandemic	3
Cerebral venous thrombosis in Behcet's disease. A report on 24 cases	3
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?	3
Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum	3
Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review	3
Treatment of hereditary amyotrophic lateral sclerosis	3